myDNA ensures the clinical reporting of pharmacogenomic results is based, where possible, on the most published PGx guidelines, such as the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Royal Dutch Pharmacists Association - Pharmacogenetics Working Group (DPWG). These guidelines are routinely updated, peer-reviewed, and published in relevant journals and can be accessed here,
The US Food and Drug Administration (FDA) has also recently published a list of medications with pharmacogenomic associations and recommendations, which are referenced, where relevant, in the myDNA PGx report: https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations
Downloadable Resources
